In the October 1992 issue of this publication, I wrote an article about the cancer prevention potential of green tea extract. I based my article on about 100 scientific papers.
If you search the National Library of Medicine database today, you’ll find over 1,000 studies relating to green tea and overall cancer prevention.
In June 2005, the FDA went to considerable effort to publish a position paper stating:
This prompted me to write a rebuttal in the November 2005 issue of this magazine exposing flaws and omissions in the FDA’s report.
The most egregious omission was a study presented at the 96 American Association for Cancer Research Meeting, where men with premalignant prostate disease were given 600 mg a day of a green tea extract supplement or placebo. The men taking green tea extract were 90% less likely to progress to prostate cancer compared to the placebo group after one year.
While this study was relatively small, the FDA pretended as if this favorable data did not exist when disseminating their report questioning whether green tea had cancer protective effects.
The FDA later attacked a maker of green tea leaves that dared to state on their label: “green tea may prevent prostate and breast cancer.”
As reported in the July 2012 issue of this publication, a Federal Court ruled against FDA’s attempt to censor an anti-cancer claim on the box of these green tea leaves.
Move forward to 2017 and the totality of evidence supporting a role for green tea in cancer prevention has greatly expanded.
If you enter “green tea and prostate cancer” into the PubMed.gov database, you can review around 400 published scientific studies on this specific topic.
The preponderance of these studies shows that green tea or its polyphenol extracts may lower prostate cancer incidence. A meta-analysis published in 2017 of some of these studies reveals prostate cancer risk reduction in response to higher green tea intake.
This recent meta-analysis involved a comprehensive, systematic dose–response review to evaluate the association of green tea intake with prostate cancer risk.
This analysis of green tea catechins (polyphenols) and green tea consumption suggested a reduction in prostate cancer incidence.
Data from this March 2017 analysis found a dose-associated reduction of prostate cancer risk in men who drank green tea. The more green tea men drank, the lower their prostate cancer risk based on linear analysis.
When this study evaluated green tea polyphenol (catechin) intake, there was an associated 62% reduction in prostate cancer risk based upon three randomized controlled human trials.
Located in Tampa, Florida, Moffitt is one of 47 National Cancer Institute-designated Comprehensive Cancer Centers. It conducts clinical trials related to cancer prevention and control. Moffitt is ranked as one of the top conventional cancer hospitals in the Southeastern United States.
A team of Moffitt researchers conducted a randomized trial to assess the safety and effectiveness of the active components in green tea to prevent prostate cancer development in men who have premalignant lesions.
According to the Moffitt researchers:
The goal of the Moffitt clinical trial was to evaluate if a one-year intervention with green tea catechins could suppress prostate cancer development in men who had high-grade intraepithelial neoplasia or atypical small acinar proliferation.
The Moffitt researchers used decaffeinated green tea capsules that contained a mixture of catechins that predominantly consisted of EGCG at a dose of 200 mg twice a day.
In this study, green tea extract capsules were compared to placebo pills in men with premalignant prostate lesions over a 1-year treatment period. Overall, the difference in the number of prostate cancer cases at the end of one year between the two treatment groups was not statistically significant.
However, in men who only had high-grade intraepithelial neoplasia at the beginning of the trial, there was a lower rate of progression to prostate cancer and development of atypical small acinar proliferation in the group taking green tea extract capsules.
Atypical small acinar proliferation reflects a broad group of prostate lesions with insufficient changes in the cells to definitively diagnose prostate cancer.
In this study, men receiving the green tea extract had a decrease in PSA (prostate-specific antigen) levels, which is an indicator of reduced prostate cancer risk.
The title of the Moffitt Cancer Center press release was:
“Component in Green Tea May Help Reduce Prostate Cancer in Men at High Risk”
While we at Life Extension® are gratified to see mainstream cancer researchers conduct this study, a higher dose of green tea extract may have produced better results, as was shown in an earlier 2006 study that used 600 mg a day.
A challenge in interpreting published studies about green tea is that different doses, different study durations, and other factors make it challenging to reach consistent outcomes. Most reports conclude with the researchers stating, “More human studies are needed.”
We at Life Extension don’t disagree about the value of more human studies. The undeniable fact is that more than 160,000 American men will be diagnosed with prostate cancer this year.
If a high-potency green tea extract capsule could reduce these prostate cancer numbers anywhere near what some studies indicate, this would have an enormous beneficial impact on the health of aging men.
It is important to never rely on any single nutrient to reduce cancer risk. As has been extensively written in Life Extension Magazine®, one’s overall diet has an enormous impact on prostate and other cancer risk.
The box on the next page is a summary we published in 2016 showing marked prostate cancer risk reductions in response to healthier eating patterns.
Reviewing these findings reveals the challenges in clinical studies that seek to assess if a single nutrient prevents cancer and other diseases. For instance, if too many men in a small study group are overeating cancer-causing foods, it could negate what effect the nutrient is really having.
A number of studies have evaluated the impact of a man’s diet on his subsequent risk of prostate cancer. Other studies reveal that even after a man is diagnosed with prostate cancer, what he eats has a huge effect on survival outcomes and disease progression. Here are some published findings we reported on last year: The results of a small study showed that markers of prostate cancer were reversed in patients with clinically relevant disease who made comprehensive lifestyle changes. Such changes included eating a diet low in fat, but rich in fruits and vegetables, along with regular exercise. The findings showed that in the control group, PSA levels increased, indicating progression (worsening) of their disease. In the comprehensive lifestyle change group, PSA levels decreased, indicating a probable regression of their prostate malignancies. Those who complied most with the healthy lifestyle changes had the greatest reductions in PSA blood levels. Most interesting from this same study was a finding that took blood serum from the participants and added it to a petri dish of dividing human prostate cancer cells. Recall both groups consisted of men with clinically relevant prostate cancer. Serum from the control group inhibited tumor growth by 9%, whereas serum from the comprehensive lifestyle group inhibited tumor growth an astounding 70%. This discovery indicates that healthy lifestyle choices result in the blood of a prostate cancer patient gaining powers that impede tumor growth. A larger study consisted of 926 men with non-metastatic prostate cancer who were evaluated over a median 10-year period. The diets of these men were categorized either as a “prudent” pattern (characterized by a higher intake of vegetables, fruits, fish, legumes, and whole grains) or as a “Western” pattern (characterized by a higher intake of processed foods and red meats, as well as high-fat dairy products and refined grains). In these 926 men with clinically diagnosed prostate cancer, those who consumed the “Western” pattern diet had a 2.53-fold increase in prostate cancer-specific mortality. This was especially evident for men who consumed the most saturated fat compared to polyunsaturated vegetable fats. Secondary analysis of the data by the same group of researchers found that men who consumed more than three servings of dairy foods daily had a 76% higher all-cause mortality risk and 141% higher prostate cancer-specific risk compared to men who consumed less than one serving a day of dairy food. Another published study evaluated levels of carotenoids and vitamin E in the blood of men with recurring prostate cancer as evidenced by rising PSA. These men were previously treated with surgery or radiation but had recurring disease based on steadily elevating PSA blood levels. After three months, men with higher blood levels of lutein and zeaxanthin showed lower PSA results. After six months, men with higher blood levels of vitamin E, lycopene, and cryptoxanthin had lower PSA readings. The researchers who conducted this study concluded that “…greater intake of foods containing these micronutrients might be beneficial to men with PSA-defined PrCA [prostate cancer] recurrence.” A study of men residing in rural Pakistan found that frequent consumption of red meat and fat increased prostate cancer risk 3.4-fold. This same study showed that greater consumption of vegetables, fruit, and fluids decreased prostate cancer risk by 79% to 91%! When dietary patterns of Iranian men were evaluated in another study, there was a strong protective effect against prostate cancer in response to higher intakes of fruits and vegetables. Men in the highest intake range of plant foods like cabbage, tomatoes, apples, and pomegranate had a 67% reduced prostate cancer risk. A study of Italian men looked at dietary patterns and their association with a man’s odds of developing prostate cancer. Men who ate the most animal products or starchy foods had a 1.5-fold increased rate of prostate cancer. Men whose diets contained the most vitamins and fiber had a 7% decreased risk. These studies emanating from around the world consistently show prostate cancer risk reductions in response to healthy dietary practices. Those with preexisting prostate cancer should pay particular attention to these findings.
A fascinating article in this month’s issue describes new data showing those who consume green tea not only have lower cancer rates, but suffer fewer degenerative illnesses and live longer.
Another article reveals that nutrients like lutein used to protect against macular degeneration also improve night vision. We were the first to introduce lutein as a supplement back in 1985.
The article on page 76 further corroborates what we have long known, i.e., magnesium deficiency worsens insulin resistance, an underlying cause of type II diabetes.
Of particular interest to all of you is the article on page 24 that describes a new beverage that can function as an “alternative to coffee.”
Clinical studies reveal how this novel cocoa-spearmint drink mix boosts mental sharpness, focus, and attention, while improving microvascular circulation in the brain.
Every time you purchase a blood test, dietary supplement, or other product advertised in this magazine, you help us contribute more funds towards human age-reversal research endeavors.
By taking steps to preserve your health today, the more likely you will be able to benefit from remarkable advances emerging in the field of regenerative medicine.